Research graph
References from Conformational selection of vasopressin upon V 1a receptor binding. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1007/978-1-4615-4871-3_34
10.1007/978-1-4615-4871-3_34 · External reference
10.1038/356523a0
10.1038/356523a0 · External reference
Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor
10.1016/s0021-9258(18)47129-3 · 1994 · External reference
10.1038/357333a0
10.1038/357333a0 · External reference
10.1038/357336a0
10.1038/357336a0 · External reference
The osmoregulation of vasopressin
10.1038/ki.1976.76 · 1976 · External reference
10.1007/s00424-008-0498-1
10.1007/s00424-008-0498-1 · External reference
Vasopressin: a novel target for the prevention and retardation of kidney disease?
10.1038/nrneph.2013.22 · 2013 · External reference
Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog
10.1161/01.res.34.4.505 · 1974 · External reference
Vasopressin acts in the subfornical organ to decrease blood pressure
1997 · External reference
10.1016/0006-8993(88)90520-3
10.1016/0006-8993(88)90520-3 · External reference
10.1016/0196-9781(84)90017-2
10.1016/0196-9781(84)90017-2 · External reference
10.1126/science.7455701
10.1126/science.7455701 · External reference
10.1016/j.npep.2020.102079
10.1016/j.npep.2020.102079 · External reference
10.1016/j.yfrne.2009.05.005
10.1016/j.yfrne.2009.05.005 · External reference
10.1016/j.yhbeh.2011.10.007
10.1016/j.yhbeh.2011.10.007 · External reference
10.1016/s0006-3223(98)00142-5
10.1016/s0006-3223(98)00142-5 · External reference
10.1016/j.yfrne.2015.04.003
10.1016/j.yfrne.2015.04.003 · External reference
10.1016/0306-4530(86)90048-x
10.1016/0306-4530(86)90048-x · External reference
10.1016/j.yhbeh.2011.11.009
10.1016/j.yhbeh.2011.11.009 · External reference
ACTH, cortisol and glucose responses after administration of vasopressin in cattle and sheep
10.1007/bf00261398 · 1995 · External reference
Stimulation by vasopressin of glycogen breakdown and gluconeogenesis in the perfused rat liver
10.1042/bj1360705 · 1973 · External reference
10.1007/978-1-4684-5799-5_7
10.1007/978-1-4684-5799-5_7 · 1990 · External reference
Area postrema and sympathetic nervous system effects of vasopressin and angiotensin II
10.1046/j.1440-1681.2000.03261.x · 2000 · External reference
10.1038/356526a0
10.1038/356526a0 · External reference
10.1073/pnas.1919050117
10.1073/pnas.1919050117 · External reference
10.1371/journal.pone.0132224
10.1371/journal.pone.0132224 · External reference
10.1021/acs.jmedchem.9b01478
10.1021/acs.jmedchem.9b01478 · External reference
Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway
10.1677/erc.1.00803 · 2004 · External reference
Interaction of vasopressin and oxytocin with human breast carcinoma cells
1990 · External reference
Hemodynamic effects of infused arginine vasopressin in congestive heart failure
10.1016/s0735-1097(86)80417-x · 1986 · External reference
Cardiac output improvement by pecavaptan: a novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failure
10.1002/ejhf.2001 · 2021 · External reference
10.1681/asn.2007060688
10.1681/asn.2007060688 · External reference
The molecular basis of nephrogenic diabetes insipidus
10.1007/s001090050224 · 1998 · External reference
A Clinical investigation of nocturnal polyuria in patients with nocturia: a diurnal variation in arginine vasopressin secretion and its relevance to mean blood pressure
10.1016/j.juro.2006.03.028 · 2006 · External reference
10.1517/17460441.2013.799134
10.1517/17460441.2013.799134 · External reference
Therapeutic potential of vasopressin receptor antagonists
10.2165/00003495-200767060-00002 · 2007 · External reference
10.1002/psc.918
10.1002/psc.918 · External reference
10.1021/jp505902m
10.1021/jp505902m · External reference
A Three-site mechanism for agonist/antagonist selective binding to vasopressin receptors
10.1002/anie.201602729 · 2016 · External reference
10.1002/psc.714
10.1002/psc.714 · External reference
Determination of molecular geometry by quantitative application of the nuclear Overhauser effect
10.1021/ja00714a005 · 1970 · External reference
10.1021/acs.jcim.6b00344
10.1021/acs.jcim.6b00344 · External reference
Virtual screening strategies in drug discovery
10.1016/j.cbpa.2007.08.033 · 2007 · External reference
10.1016/j.csbj.2014.11.004 · Admitted local publication
Development of a human vasopressin V 1a -receptor antagonist from an evolutionary-related insect neuropeptide
10.1038/srep41002 · 2017 · External reference
Discovery of peptide ligands through docking and virtual screening at nicotinic acetylcholine receptor homology models
10.1073/pnas.1703952114 · 2017 · External reference
10.1021/acs.chemrev.0c01087
10.1021/acs.chemrev.0c01087 · External reference
10.1038/nprot.2016.051
10.1038/nprot.2016.051 · External reference
10.1002/prot.25802
10.1002/prot.25802 · External reference
10.1371/journal.pone.0058769
10.1371/journal.pone.0058769 · External reference
Conformation and dynamics of 8-Arg-vasopressin in solution
10.1007/s00894-014-2485-0 · 2014 · External reference
10.1002/jcc.21334
10.1002/jcc.21334 · External reference
1001 Ways to run AutoDock Vina for virtual screening
10.1007/s10822-016-9900-9 · 2016 · External reference
10.1074/jbc.270.43.25771
10.1074/jbc.270.43.25771 · External reference
Cis/trans conformational equilibrium across the cysteine6-proline peptide bond of oxytocin, arginine vasopressin, and lysine vasopressin
10.1021/ja00045a001 · 1992 · External reference
Dynamics of cis/trans isomerization of the cysteine6-proline peptide bonds of oxytocin and arginine-vasopressin in aqueous and methanol solutions
10.1021/ja00060a033 · 1993 · External reference
Folding of immunogenic peptide fragments of proteins in water solution: I. Sequence requirements for the formation of a reverse turn
10.1016/0022-2836(88)90446-9 · 1988 · External reference
10.1152/physrev.00035.2011
10.1152/physrev.00035.2011 · External reference
10.1016/s0079-6123(08)00437-8
10.1016/s0079-6123(08)00437-8 · External reference
10.1111/j.1365-2826.2012.02303.x
10.1111/j.1365-2826.2012.02303.x · External reference
10.1021/acs.jafc.0c04502
10.1021/acs.jafc.0c04502 · External reference
Pharmacological characterization of F-180: a selective human V1a vasopressin receptor agonist of high affinity
10.1038/sj.bjp.0704634 · 2002 · External reference
10.1016/j.jmb.2019.11.015
10.1016/j.jmb.2019.11.015 · External reference
Cis peptide bonds in proteins: residues involved, their conformations, interactions and locations
10.1006/jmbi.1999.3217 · 1999 · External reference
10.1677/joe.0.1560223
10.1677/joe.0.1560223 · External reference
Synthesis and biological activities of arginine-vasopressin analogs designed from a conformation-activity approach
10.1021/jm00194a008 · 1979 · External reference
10.1002/psc.394
10.1002/psc.394 · External reference
10.1039/d0sc05501h
10.1039/d0sc05501h · External reference
10.1126/scitranslmed.aat7838
10.1126/scitranslmed.aat7838 · External reference
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
10.1007/bf00197809 · 1995 · External reference
10.1093/bioinformatics/btu830
10.1093/bioinformatics/btu830 · External reference
Trypsin inhibition by a peptide hormone: crystal structure of trypsin-vasopressin complex
10.1016/j.jmb.2005.03.034 · 2005 · External reference
10.1093/bioinformatics/btu426
10.1093/bioinformatics/btu426 · External reference
Increasing the precision of comparative models with YASARA NOVA—a self-parameterizing force field
10.1002/prot.10104 · 2002 · External reference
10.1021/jp907388m
10.1021/jp907388m · External reference
10.1063/1.470117
10.1063/1.470117 · External reference
10.1063/1.470043
10.1063/1.470043 · External reference
